51768-59-3

Δ⁸-THCB (exempt preparation) is an analytical reference standard that is structurally similar to known phytocannabinoids. Δ⁸-THCB is regulated as a Schedule I compound in the United States. Δ⁸-THCB (exempt preparation) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.

Δ8-THCB (?8-Tetrahydrocannabutol) is a structural analog of phytocannabinoids. Δ8-THCB is also an analog of Δ8-tetrahydrocannabinol[1].

[1] Tagen M, et al. Review of delta-8-tetrahydrocannabinol (Δ8 -THC): Comparative pharmacology with Δ9 -THC. Br J Pharmacol. 2022 Aug;179(15):3915-3933. doi: 10.1111/bph.15865. Epub 2022 Jun 1. Erratum in: Br J Pharmacol. 2023 Jan;180(1):130. DOI:10.1111/bph.15865